The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...

During the NFL scouting combine, mock drafts fell in love with the idea of Penn State guard Olaivavega Ioane falling to the Ravens with the No. 14 pick. ESPN, The Athletic and The Ringer, among others ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.

March 4, 2026 - The U.S. Food and Drug Administration on Tuesday announced the issuance of 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 ...

A Kentucky lawmaker has filed a new bill that would strengthen oversight of compounded drugs, including weight loss ...

A bipartisan bill at the state capitol in Denver is targeting compounded versions of popular weight loss drugs like Ozempic, Wegovy, and Zepbound, known as GLP-1s.

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators say some companies im ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...